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Abstract
Environmental factors such as diet, intake of vitamin D supplements and exposure to sunlight are known to influence serum
vitamin D concentrations. Genetic epidemiology of vitamin D is in its infancy and a better understanding on how genetic
variation influences vitamin D concentration is needed. We aimed to analyse previously reported vitamin D-related
polymorphisms in relation to serum 25(OH)D concentrations in 201 healthy Danish families with dependent children in late
summer in Denmark. Serum 25(OH)D concentrations and a total of 25 SNPs in GC, VDR, CYP2R1, CYP24A1, CYP27B1, C10or88
and DHCR7/NADSYN1 genes were analysed in 758 participants. Genotype distributions were in Hardy–Weinberg equilibrium
for the adult population for all the studied polymorphisms. Four SNPs in CYP2R1 (rs1562902, rs7116978, rs10741657 and
rs10766197) and six SNPs in GC (rs4588, rs842999, rs2282679, rs12512631, rs16846876 and rs17467825) were statistically
significantly associated with serum 25(OH)D concentrations in children, adults and all combined. Several of the SNPs were in
strong linkage disequilibrium, and the associations were driven by CYP2R1-rs10741657 and rs10766197, and by GC-rs4588
and rs842999. Genetic risk score analysis showed that carriers with no risk alleles of CYP2R1-rs10741657 and rs10766197,
and/or GC rs4588 and rs842999 had significantly higher serum 25(OH)D concentrations compared to carriers of all risk
alleles. To conclude, our results provide supporting evidence that common polymorphisms in GC and CYP2R1 are associated
with serum 25(OH)D concentrations in the Caucasian population and that certain haplotypes may predispose to lower
25(OH)D concentrations in late summer in Denmark.
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Introduction
Vitamin D deficiency is a widespread problem in developed
countries [1]. Severe vitamin D deficiency causes osteomalacia, or
childhood rickets, osteoporosis and fractures because of reduced
calcium absorption [2]. Low vitamin D concentrations may also be
related to various non-skeletal health outcomes, including cardio-
vascular diseases [3], obesity [4], diabetes [5], asthma [6], multiple
sclerosis [7], occurrence of a large range of cancer diseases [8] and
overall mortality [9,10].
In humans, vitamin D is produced mainly in the skin during
exposure to solar ultraviolet blue (UVB) radiation (270–300 nm)
[11]. UVB radiation converts 7-dehydrocholesterol (7-DHC) in
the skin to pre-vitamin D3, which immediately undergoes a
thermal isomerization to vitamin D3. Dietary sources provide two
forms of vitamin D: Vitamin D2 (ergocalciferol) derived from
invertebrates (plants and fungi) and vitamin D3 (cholecalciferol)
derived from animal sources. Ingested vitamins D2 and D3 are
absorbed in the small intestine and transported with chylomicrons
and lipoproteins to the liver, whereas dermally synthesized vitamin
D3 diffuses via the blood to the liver tightly bound to group-
specific complement (GC) [12].
Dietary or dermally synthesized vitamin D (hereafter ‘‘D’’ refers
to D2 and D3) undergoes a series of enzymatic conversions in the
liver and kidneys to become biologically active. The hepatic
enzyme 25-hydroxylase (CYP2R1) converts vitamin D to 25-
hydroxyvitamin D (25(OH)D). This is the major circulating form
of vitamin D in the blood. To become biologically active,
25(OH)D is converted to 1,25-dihydroxyvitamin D
(1,25(OH)2D). This occurs mainly in the kidneys, but also in
other tissues expressing the enzyme 25(OH)D-1a-hydroxylase
(CYP27B1). The biological effect of vitamin D is mediated when
1,25(OH)2D binds to the vitamin D receptor (VDR). To prevent
excessive vitamin D signalling in the target organs, 1,25(OH)2D
limits its own activity by inducing 24-hydroxylase (CYP24A1)
converting 1,25(OH)2D to the biologically inactive water-soluble
calcitroic acid which is excreted in the bile [1,12,13].
The best biomarker of vitamin D concentration is the serum
25(OH)D concentration. Approximately 25% of the inter-individ-
ual variability in plasma 25(OH)D concentrations can be
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explained by external factors such as diet, regular use of vitamin D
supplements and exposure to sunlight (dependent on season and
latitude) [14,15]. Genetic factors may contribute to vitamin D
concentrations. Results from twin and family-based studies
indicate that blood vitamin D concentrations to some extent are
under genetic control. The results have been inconsistent with a
wide variability in heritability estimates ranging from 23 to 80%
[15–21]. Furthermore, ethnic differences in vitamin D concentra-
tions have also been described [22].
Genetic epidemiology of vitamin D is in its infancy and a better
understanding of how genetic variation influences vitamin D
concentrations is needed. A growing number of studies have
uncovered polymorphisms associated with vitamin D concentra-
tions. By candidate gene analysis, five genes have been found,
including GC, CYP24A1, CYP2R1, CYP27B1 and VDR [23].
Recently, two genome-wide association studies (GWAS) of vitamin
D [24,25] confirmed the associations of common variants in GC
and CYP2R1 genes. Furthermore, nicotinamide adenine dinucle-
otide synthetase-1/7-dehydrocholesterol reductase (NADSYN1/
DHCR7), and the region harbouring the open-reading frame 88
(C10orf88) on chromosome 10q26.13 were also found to be
associated with vitamin D concentrations in blood.
In Denmark, low vitamin D status is common during the winter
due to inadequate dietary intakes and lack of solar radiation from
September to April [26]. We assessed vitamin D status in late
summer (September to October), where the Danes vitamin D
concentration peaks but are not saturated [27], in families with a
broad span in age in both children and adults. In children, the role
of genetic variation in determining serum 25(OH)D concentra-
tions is an understudied area.
In this study, we analysed previously reported vitamin D-related
polymorphisms in relation to serum 25(OH)D concentrations in
201 healthy Danish families with dependent children to confirm
previous findings and thus help identifying individuals that may
have increased risk of developing vitamin D insufficiency.
Subjects and Methods
Study population
The present cross-sectional study used baseline data from the
VitmaD intervention study described in detail elsewhere [28].
Briefly, 201 Danish families with dependent children (n= 782)
were enrolled. The participants were 4- to 60-years old. Baseline
blood samples were collected in September and October 2010 and
were obtained from 770 participants. The study was conducted
according to the guidelines in the Declaration of Helsinki and the
protocol was approved by the Research Ethics Committee of the
Capital Region of Denmark (H-4-2010-020) and registered at
http://clinicaltrials.gov (NCT01184716). All adult participants
and guardians on the behalf of the children participants gave
written consent to participate.
DNA extraction and genotyping
DNA was extracted from peripheral blood leukocytes as
described by Miller et al. [29] and stored in TE-buffer at -80uC.
The DNA was diluted to 10 ng/ml using a NanodropH ND-1000
Spectrophotometer (Thermo Fisher Scientific Inc., Wilmington).
Single nucleotide polymorphisms (SNPs) were genotyped using the
Sequenom MassARRAY iPLEX Gold platform (Sequenom, San
Diego, California) at the Department of Biomedicine, Aarhus
University, Denmark. Genotyping was successful for 762 partic-
ipants (99.0%). To confirm the accuracy of genotyping duplicate
samples (10%) yielded 100% reproducibility.
All SNPs were located in or near genes involved in vitamin D
synthesis, activation or degradation. The following SNPs were
selected on the basis of evidence of significant association in
previous studies: CYP2R1 (rs1562902; rs7116978; rs10741657;
rs10766197) CYP24A1 (rs229624; rs2426496; rs4809960;
rs6013897; rs17219315) CYP27B1 (rs10877012) C10orf88
(rs6599638) DHCR7/NADSYN1 (rs1790349; rs12785878) GC
(rs4588; rs222020; rs842999-triallelic; rs2882679; rs2298849;
rs12512631; rs16846876; rs17467825) VDR (rs731236 (TaqI),
rs757343 (TruI); rs7139166; rs10783219).
Deviation from Hardy–Weinberg equilibrium (HWE) was
tested for the adult population using Chi-square test with
Bonferroni’s correction (P-value 0.05/25 SNPs= 0.002). No
significant deviation from HWE was observed. Linkage disequi-
librium (LD) between polymorphisms was evaluated using
Pearsons’ r, SNAP version 2.2 (http://www.broadinstitute.org/
mpg/snap/ldsearchpw.php) and Haploview software version 4.2
for the adult population.
Measurement of serum 25(OH)D concentrations
Measurements of serum 25(OH)D concentrations are described
in detail elsewhere [28]. Briefly, blood samples were obtained
without prior fasting and serum was stored in aliquots at –80uC
until analysis. Measurements of serum 25(OH)D concentrations
relied on the determination of both 25(OH)D2 and 25(OH)D3 and
were conducted by isotope dilution liquid chromatography
tandem mass spectrometry (LC-MS/MS) at Clinical Biochemical
Department, Holbæk Hospital, Denmark. As primary calibrator
the standard reference material, vitamin D in humans (SRM 972)
from the National Institute of Standards and Technology was
used. The analytic quality of 25(OH)D assay was assured by
Vitamin D External Quality Assessment Scheme certification and
the mean bias was –3.2%. The Inter-assay CVs for 25(OH)D2
were 7.6% and 4.6% at 43 and 150 nmol/L, respectively, and for
25(OH)D3 2.2% and 2.8% at 30 and 180 nmol/L, respectively
[28]. Of the 762 participants that were successfully genotyped,
baseline serum 25(OH)D concentrations were measured for 758
participants.
Statistical analysis
Statistical analyses were performed using SAS Enterprise Guide
4.3 (SAS Institute, Inc., Cary. USA). Serum 25(OH)D concentra-
tions were log transformed to approximate a normal distribution
and all means are presented as geometric means. A nominal P-
value of 0.05 was considered statistically significant. Linear mixed
models with family as a random factor were applied to account for
the possible dependence between the participants. Furthermore, in
the linear mixed models the following categorical variables were
included: age (4–11, 12–17, 18–40, 41–60 years), sex (male,
female), BMI (underweight, normal weight, overweight, obese)
according to standards for children [30] and the WHO
International standards for adults [31], ski or sun holidays (yes,
no), solarium use at least once a week (yes, no), dietary vitamin D
(quartiles: ,1.7, 1.7–2.4, 2.5–3.3 and .3.3 mg/d), multivitamin
and vitamin D supplement users (yes, no). The data were obtained
from a self-administered web-based questionnaire and a semi-
quantitative food frequency questionnaire based on the last six
months. Pearson’s r were calculated on the adult population and
were used to assess the degree of linkage between linked SNPs.
Haplotypes were inferred manually among the adults, only since
the children were not population-based. The inferred haplotype
combinations described 100% and 97% of the observed genotypes
among the adults for CYP2R1 and GC genes, respectively. Among
the children the inferred haplotype combinations described 100%
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and 96% of the observed genotypes for CYP2R1 and GC genes,
respectively. Each derived haplotype was assigned a number.
Homozygote haplotype combinations were numbered with two
identical numbers e.g. 11. The combinations of heterozygote
haplotypes were given by the combination of the number of each
haplotype e.g. 1+ 2= 12.
Genetic risk scores were calculated as the sum of risk alleles and
included as risk factors in linear mixed models adjusted for family
and confounding variables. The correlation coefficient for
rs10741657, rs10766197, rs4588 and rs842999 were very similar
and therefore it was not necessary to weight the score by effect
size. All the analyses were performed separately for children,
adults and for all combined.
Results
Genotyping and serum 25(OH)D concentrations were available
for 758 participants. Table 1 summarizes the basic characteristics
of the study population, previously described in detail elsewhere
[28]. The median age among children was 10 years (range: 4 to17)
among adults 41 years (range: 18 to 60) and for all combined 30
years.
Associations between genotypes and serum 25(OH)D concen-
trations are shown for children, adults and all combined in Table
2. After adjustment for family and confounding factors, all four
analysed SNPs in CYP2R1 were statistically significantly associated
with serum 25(OH)D concentrations in all three groups. Further-
more, for all three groups none of the analysed SNPs in CYP24A1,
CYP27B1, C10orf88 and DHCR7/NADSYN1 were statistically
significantly associated with serum 25(OH)D concentration. For
all three groups all analysed SNPs in GC, except rs2298849 (in all
three groups) and rs222020 (in adults and all), were statistically
significantly associated with serum 25(OH)D concentration. The
VDR rs731236 was only statistically significantly associated with
25(OH)D concentration in all combined and rs757343 was
statistically significant in children and all combined. Only SNPs
that were statistically significantly associated with 25(OH)D
concentrations in children, adults and all combined were included
in further analyses.
Haplotype and genetic risk score analysis of CYP2R1
In the adult population, rs10741657-rs7116978 (Pearson’s r
= 0.90), and rs1076697-rs1562902 (Pearson’s r = –0.86, data not
shown) were in strong LD. To establish which of the SNPs had the
strongest association to serum 25(OH)D concentrations, we assess
the association between one SNP and serum 25(OH)D concen-
trations while adjusting for the other SNPs, family and confound-
ing factors in a linear mixed model. After adjustment, rs10766197
(p = 0.0846) had the strongest association compared to rs1562902
(p = 0.8211), and rs10741657 (p= 0.2545) had the strongest
association compared to rs7116978 (p= 0.3087, data not shown).
In further analysis only rs1076697 and rs10741657 were included.
The two CYP2R1 variants rs10741657 and rs7116978 formed
four haplotypes, where haplotype 1 and 2 were most frequent
(Table 3). The possible combinations of the four homozygote
haplotype are shown in table 3. One genotype combination could
be assigned to both haplotype combinations 12 or 34, but based on
the observed haplotype frequencies, the most likely combination
was 12. After adjustment for family and confounding factors,
carriers of 2 copies of the AG-haplotype (haplotype combination
33) had the highest mean serum 25(OH)D concentration (73.8
(60.1–90.6), 72.9 (57.3–92.5) and 81.3 (66.4–99.6) nmol/L) in
children, adults and all combined, respectively. In a linear mixed
model, only the homozygous haplotype combinations were
included and haplotype combination 44 was excluded because
only two participants carried this haplotype combination. The
homozygous haplotype combinations were significantly associated
with serum 25(OH)D concentrations (p = 0.0059, 0.0450 and
0.0007) in children, adults and all combined, respectively.
We calculated a genetic risk score (range 0–4) as the sum of the
number of G-alleles of rs10741657 and A-alleles of rs10766197
(Figure 1, A). After adjustment for family and confounding factors,
carriers of no risk alleles had significantly higher serum 25(OH)D
concentrations (74.0 (60.3–90.0), 73.0 (57.5–92.6) and 81.3 (66.4–
99.5) nmol/L) compared to carriers of all four risk alleles (61.2
(57.5–92.6), 64.0 (50.6–80.9) and 69.8 (57.0–85.4) nmol/L) in
children, adults and all combined, respectively. Overall, there was
20.9, 14.1 and 16.5% difference in serum 25(OH)D concentra-
tions between carrying no risk alleles and carrying all four risk
alleles in children, adults or all combined, respectively.
Haplotype and genetic risk score analysis of GC
In the adult population, rs4588 was in strong LD with
rs2282679 (Pearson’s r = 0.997), rs17467825 (Pearson’s r = 0.997)
and rs16846876 (Pearson’s r = 0.805). Furthermore, rs17467825-
rs2282679 (Pearson’s r = 1.00), and rs2282679-rs16846876 (Pear-
son’s r = 0.8021, data not shown) were also in strong LD. To
establish which of the 4 SNPs had the strongest association to
serum 25(OH)D concentrations, we assess the association between
one SNP and serum 25(OH)D concentrations while adjusting for
Table 1. Basic characteristics of the study population and determinants of serum 25(OH)D concentrations
Characteristics Children Adults All
Number 348 414 762
Female/Male (n/n) 181/167 209/205 390/372
Age, median (range) 10 (4–17) 41 (18–60) 30 (4–60)
BMI (kg/m2)* 17.4462.89 25.4764.30 21.7965.45
Serum 25(OH)D (nmol/L)* 74.38617.31 74.87621.70 74.65619.82
Dietary Vitamin D (mg/d)* 2.6961.35 2.9662.04 2.8461.77
Multivitamin or vitamin D supplement users (yes/no) 141/203 113/297 254/500
Solarium use (yes/no) 2/342 10/401 12/743
Ski or sun holidays (yes/no) 195/149 220/191 415/340
*Mean 6 SD.
doi:10.1371/journal.pone.0089907.t001
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the other SNPs, family and confounding factors in a linear mixed
model. The strongest association was observed for rs4588
(p = 0.0099) compared to rs2282679 (p = 0.0230), rs17467825
(p = 0.0230) and rs16846876 (p = 0.5669, data not shown). Further
analyses only included rs4588. None of the other GC-variants were
in LD.
The three significant GC-variants (rs4588, rs842999, and
rs12512631) formed five haplotypes, where haplotype 1 and 2
were the most frequent (Table 4). The combinations of the five
haplotypes are shown in table 4. The five haplotypes could explain
723 of the 762 (95%) observed genotype combinations in GC (data
not shown). The association between haplotype combinations and
serum 25(OH)D concentrations was statistically significant in
children (p = 0.0344), and all combined (p = 0.0018) but not in
adults (p = 0.1541).
Carriers of haplotype combination 22 encompassing the variant
alleles of rs4588 and rs842999 had low serum 25(OH)D
concentrations. Conversely, carriers of haplotype combination
11 encompassing the variant allele of rs12512631 had high serum
25(OH)D concentration. Thus, the variant allele of rs12512631
was associated with high low serum 25(OH)D concentrations and
the variant alleles of rs4588 and rs842999 were associated with low
serum 25(OH)D concentrations. Since the lowest serum 25(OH)D
concentrations were observed for haplotype combination 22
carriers, this could indicate that rs4588 is the biologically relevant
polymorphism rather than rs842999 since haplotype combination
44 encompassing the C-allele of rs842999 is associated with higher
serum 25(OH)D concentrations.
The genetic risk score (range 0–4) was calculated as the sum of
the number of A-alleles of rs4588 and C/A-alleles of rs842999
(Figure 1, B). After adjustment for family and confounding factors,
we found that an increasing number of risk alleles was associated
with lower serum 25(OH)D concentrations. Carriers of no risk
alleles had significantly higher serum 25(OH)D concentrations
(68.1 (56.2–82.6), 81.0 (64.2–102.2) and 86.5 (70.9–105.5) nmol/
L) compared to carriers of all four risk alleles (50.3 (40.3–62.7),
67.5 (53.6–84.9) and 70.1 (57.2–84.8) nmol/L) in both children,
adults and all combined, respectively. Overall, there was a mean
difference in 25(OH)D concentrations of 35.4, 20.0 and 23.4%
between carrying no risk alleles and carrying all four risk alleles in
children, adults and all combined, respectively.
For the tri-allelic variant rs842999, there was a dose-dependent
relationship between serum 25(OH)D concentrations and carriage
of none, one or two copies of the G-allele (Figure 2). Thus, carriers
of two copies of the G-allele, had statistically significantly higher
serum 25(OH)D concentrations (69.2 (56.8–84.3), 79.0 (62.8–99.4)
and 84.8 (69.6–103.4) nmol/L) compared to carriers of only one
G–allele (65.6 (53.9–79.9), 73.7 (58.8–92.4) and 79.0 (64.9–96.1)
Figure 1. Genetic risk score for CYP2R1 (rs10741657 and rs10766197) (Figure A), GC (r4588 and rs842999) (figure B) and CYP2R1
(rs10741657 and rs10766197) and GC (r4588 and rs842999) (figure C) in children, adults and all combined. X-axis stands for the sum of
risk alleles. Y-axis stand for serum 25(OH)D (nmol/L). Errors bars stand for 95%-confidence interval and serum 25(OH)D concentrations are given as
geometric means. Linear mixed models with family as a random factor, adjusted for age, sex, BMI, ski and sun holidays, solarium use at least once a
week, dietary vitamin D intake, multivitamin and vitamin D supplement users was conducted to compare sum of risk alleles and serum 25(OH)D
concentrations. Increasing number of risk alleles give rise to decreasing 25(OH)D concentrations.
doi:10.1371/journal.pone.0089907.g001
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nmol/L) in children, adults and all combined, respectively. The
lowest serum 25(OH)D concentrations were observed in non-
carriers of the G-allele (59.5 (48.7–72.6), 67.4 (53.8–84.4) and 72.8
(59.7–88.8) nmol/L) in both children, adults and all combined,
respectively.
Finally, we made a joint genetic risk score analysis including
CYP2R1 (rs10741657 and rs10766197) and GC (rs4588 and
rs842999) (Figure 1, C). The genetic risk score (range 0–8) was
calculated as the sum of the number of G-alleles of rs10741657, A-
alleles of rs10766197, A-alleles of rs4588 and C/A-alleles of
rs842999 (Figure 1, C). After adjustment for family and
confounding factors, carriers of no risk alleles had statistically
significantly higher 25(OH)D concentrations (78.4 (63.6–96.7),
86.3 (66.1–112.7) and 89.0 (72.0–110.0) nmol/L) compared to
carriers of all eight risk alleles 43.4 (32.4–58.2), 55.3 (37.5–81.4)
and 53.0 (39.6–70.9) nmol/L) in children, adults and all
combined, respectively. Overall there was a mean difference in
25(OH)D concentrations of 80.6, 56.1 and 67.9% between
carriage of no risk alleles and carriage of all four risk alleles in
children, adults and all combined, respectively.
Discussion
In this present study, we studied the association of 7 prominent
vitamin D-related genes with serum 25(OH)D concentrations in
201 Danish families with dependent children in late summer in
Denmark, and found that common variants in CYP2R1 and GC
genes were statistically significantly associated with serum
25(OH)D concentrations.
The CYP2R1 gene encodes the key enzyme that converts
vitamin D to 25(OH)D in the liver [12] and thus genetic variation
in this gene might affect 25(OH)D synthesis. We found that
CYP2R1 variants rs1562902, rs7116978, rs10741657 and
rs10766197, were significantly associated with serum 25(OH)D
concentrations in both children, adults and all combined.
Furthermore, rs10741657-rs7116978, and rs10766197-rs1562902
were in strong LD. The association appeared to be driven by
rs10741657 and rs10766197, which are located in the promoter
region of the CYP2R1 gene. We found that non-carriers of
rs10741657 and rs10766197 risk alleles had the highest mean
serum 25(OH)D concentrations.
Our results are consistent with previous findings. In the study of
Wjst et al. [21], rs10766197 was significantly associated with
25(OH)D concentrations in 872 subjects from the German
Asthma Family Study. Ramos-Lopez et al. [32] found a
statistically significant association between rs10741657 and serum
25(OH)D concentrations in 203 German diabetes families. Two
genome-wide association studies (GWAS) of vitamin D concen-
trations were published in 2010 [24,25]. Ahn et al. [24] performed
a combined meta-analyses in 4,501 subjects from five adult
Caucasian cohorts and found that rs2060793, which is in LD with
rs10741657 (D= 1, r2 = 1, HapMap Data Rel 24/phase II Nov
08), was associated with serum 25(OH)D concentrations. Further-
more, these findings were successfully replicated in 2,221 subjects.
Wang et al. [25] found that rs10741657 was significantly
associated with 25(OH)D concentrations in 30,000 subjects of
European descent from 15 cohorts. In the study of Bu et al. [33],
rs10741657 and rs10766197 were found to be significantly
associated with serum 25(OH)D concentrations in 496 unrelated
healthy Caucasian subjects. Lasky-Su et al. [34] conducted a
combined analysis in 1,164 subjects from two cohorts of Caucasian
and Costa Rica asthmatic children and found that rs10741657 was
significantly associated with 25(OH)D concentrations. Zhang et al.
[35] found that rs10766197 was significantly associated with
25(OH)D concentrations in 2,897 unrelated healthy Chinese
subjects from the Shanghai Osteoporosis Study. In the study of
Engelman et al. [36], rs2060793 (in LD with rs10741657 as
mentioned previously) was significantly associated with 25(OH)D
concentrations in 1,204 women of European descent from the
Women’s Health Initiative Observational Study. All the afore-
mentioned studies demonstrate that variants in the CYP2R1 gene
predicts 25(OH)D concentrations.
The GC gene encodes the vitamin D binding protein (DBP) that
binds and transports blood 25(OH)D and other vitamin D
metabolites to their target organs. Less than 0.04% of blood
25(OH)D circulates in free form (bioavailable). Most is bound with
high affinity to DBP (83–85%) and with lower affinity to albumin
Figure 2. Dose-dependent relationship between genotype GG, GX and XX of rs842999 and serum 25(OH)D concentrations. X-axis
stands for genotype GG (GG), GX (GC or GA) and XX (CC, CA or AA) of rs842999. Y-axis stand for serum 25(OH)D (nmol/L). Errors bars stand for 95%-
confidence interval and serum 25(OH)D concentrations are given as geometric means. Linear mixed models with family as a random factor, adjusted
for age, sex, BMI, ski and sun holidays, solarium use at least once a week, dietary vitamin D intake, multivitamin and vitamin D supplement users was
conducted to compare rs842999 genotypes with serum 25(OH)D concentrations. There was a dose-dependent relationship between serum 25(OH)D
concentrations and carriers of none, one or two copies of the G-allele. Carriers of two copies of the G-allele, had higher serum 25(OH)D
concentrations compared to carriers with only one G-allele or non-carriers in children, adults and all combined, respectively.
doi:10.1371/journal.pone.0089907.g002
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(12–15%) [37]. Variants in the GC gene may affect the DBP
binding and bioavailability of 25(OH)D and other vitamin D
metabolites. Thus, there may be a relationship between phenotype
and blood 25(OH)D concentrations.
There is accumulating evidence that variants in the GC gene are
associated with 25(OH)D concentrations. The most studied GC-
variants are rs4588 and rs7041, giving three common GC-
isoforms, GC1F (rs7041-T, rs4588-C), GC1S (rs7041-G, rs4588-
C), and GC2 (rs7041-T, rs4588-A), which differ by amino acid
substitutions and/or by glycosylation (Gozdzik et al. 2011). Several
studies have shown that vitamin D status differs significantly
depending on rs4588 and/or rs7041 genotype, where the A-allele
of rs4588 and the T-allele of rs7041 are consistently associated
with lower 25(OH)D concentrations [17,38–45]. In agreement, we
found that the A-allele of rs4588 is associated with lower 25(OH)D
concentrations. There is biological support that the affinity of both
25(OH)D and 1,25(OH)2D is higher for the C-allele of rs4588 than
for the A-allele [46]. Based on glycosylation patterns, it is
suggested that GC2 phenotypes that is associated with low vitamin
D concentrations should be metabolized faster. Kawakami et al.
observed that the metabolic rate was indeed higher in GC2-2
individuals than in GC1-1 individuals [47]. In addition, the GC2
genotype, which is associated with low 25(OH)D concentrations, is
also associated with low mean DBP [43]. Strangely, the GC2
genotype is more frequent in populations living in northern
climates [48].
Since the two GWAS studies [24,25] found a strong association
between rs2282679 and 25(OH)D concentrations, there has been
increased focus on this polymorphism. Several studies have been
published supporting the finding [22,34,35,49–51]. The GWAS
GC variant rs2282679 is in high LD with rs4588. Wang et al. [25]
did not include rs4588 because it is not in the HapMap dataset. In
one study sample the authors found that rs4588 was in LD with
several associated variants from the GWAS study. In the study of
Lu et al. [45], rs4588 and rs2282679 (r2 = 0.97) were significantly
associated with 25(OH)D concentrations in 3,210 Han Chinese. In
the study by Berry et al. [52], rs4588 was in strong LD with
rs228697 (r2 = 0.98), and rs4588 was significantly associated with
25(OH)D concentrations in 6,551 subjects from the British birth
cohort. Zhang et al. [35] found that 2282679 and rs4588 were in
strong LD in 2,897 unrelated healthy Chinese subjects and the
strongest association was observed for rs4588, which accounted for
0.7% of the variation in serum 25(OH)D concentrations. Our
results support that rs228697 is in strong LD with rs4588
(Pearson’s r = 0.997, SNAP proxy D’ = 1 r2 = 0.98) and that the
association with serum 25(OH)D concentrations is most likely
driven by rs4588. Zhang et al. [35] argued that it is unlikely that
rs2282679 in itself is the disease-causing variant. The possible
causal variant is the non-synonymous rs4588, where the C/A base
pair change in codon 436 (previously known as 420 [36]) causes a
Thr to Lys amino acid substitution. In agreement with Zhang et al.
[35] we found that rs4588 was the strongest independent predictor
of 25(OH)D concentrations compared to rs2282679. Furthermore,
Zang et al [35] found that both the minor T-allele of rs4588 and
G- allele of rs2282679 were associated with reduced DBP
concentrations. Participants with 3 or 4 risk alleles of the two
variants were more likely to have vitamin D concentrations lower
than 50 nmol/L (20 ng/mL) compared with non-carriers of the
risk alleles.
In our study, several of the significant GC variants were in strong
LD and the strongest associations with serum 25(OH)D concen-
trations were observed for rs4588 and rs842999. We observed a
dose-dependent relationship between carrying none, one or two
copies of the G-allele of the tri-allelic rs842999 and 25(OH)D
concentrations. Furthermore, genetic risk score analysis for rs4588
and rs842999 showed that non-carriers of the risk alleles of rs4588
and rs842999 had the highest serum 25(OH)D concentrations.
We made a joint genetic risk score analysis for all four risk
variants (CYP2R1-rs10741657 and rs10766197, and GC-rs4588
and rs842999), and found the largest%-range in mean serum
25(OH)D concentrations (80.6, 56.1 and 67.9%) compared to
genetic risk score analysis of CYP2R1 (rs10741657 and
rs10766197; 20.9, 14.1 and 16.5%) or GC (rs4588 and rs842999;
35.4, 20.0 and 23.4%) indicating an additive effect. In general,
there was a better association between genetic risk score and serum
25(OH)D concentrations in children than in adults. We speculate
that the more risk alleles in CYP2R1 and GC genes a subject
carries, the more prone the subject will be for having a low serum
25(OH)D concentration. In Denmark, sufficient serum 25(OH)D
concentrations are defined as .50 nmol/L [53]. Notably, in late
summer in Denmark, where vitamin D status peaks in Danes,
children carrying 7 or 8 risk alleles had insufficient serum
25(OH)D concentrations (49.4 and 43.4 nmol/L).
In our study population, none of the investigated SNPs in
CYP24A1, CYP27B1, C10orf88 or DHCR7/NADSYN1 were associ-
ated with serum 25(OH)D concentrations. Furthermore, VDR-
rs731236 was only statistically significant in all combined and
rs757343 was statistically significant in children and all combined.
False-positive (type 1 errors) results, which are common in studies
of the association between genetic markers and outcomes, and the
relative small sample size, resulting in statistical reduced power
might explain these findings. We consider children and adults as
two natural subpopulations due to biological differences, difference
in lifestyle, eating patterns and use of multivitamins [28]. We did
not use Bonferroni-corrected P-values because a statistically
significant association both in children and in adults by itself
may be considered a confirmation of an association. A limitation
of the study is that the participants’ general vitamin D status relies
on a single measurement of serum 25(OH)D concentration. We
were not able to calculate the genetic contribution due to the
familiar design used in the linear mixed model. A strength of this
study is that it is conducted in a healthy Caucasian population and
thus the potential impact of diseases is minimized. Furthermore,
the blood samples were collected in a relatively small geographical
area in Denmark in September to October 2010 and analysed in a
single batch with LC-MS/MS with low variation. Furthermore,
many known predictors of serum 25(OH)D concentrations were
assessed by questionnaire data.
Genetic variants may accelerate or protect against vitamin D
deficiency and the genetic effect is life-long. We speculate that
individuals with genetically determined low vitamin D concentra-
tions may need different health recommendations in order to
improve their serum 25(OH)D concentrations thereby avoiding
adverse health outcomes. A study by Engelman et al. [36] found
that in women with no risk alleles of rs4588 and rs2060793 (in
strong LD with rs10741657 as mentioned previously) who
consumed at least 670 IU/d vitamin D all (100%) had 25(OH)D
. 50 nmol/L. For women carrying 1, 2 or 3–4 risk alleles and
consuming at least 670 IU/d vitamin D, only 84, 72, and 62% had
25(OH)D . 50 nmol/L. Furthermore, the percentage of women
with adequate 25(OH)D concentrations rose with each increasing
quartile of vitamin D intake. Thus, subjects with genetic
predisposition seem to benefit from dietary vitamin D supplemen-
tation. In the study by Madsen et al. [28], vitamin D3-fortification
of bread and milk reduced the decrease in serum 25(OH)D
concentrations seen during winter and ensured 25(OH)D
.50 nmol/L in healthy Danish families. Whether such a dietary
intervention program could ensure adequate serum 25(OH)D
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concentrations in subjects with genetic predisposition for vitamin
D deficiency warrants further study.
Conclusions
In conclusion, our results support the current evidence that
common genetic variation in GC and CYP2R1 may contribute to
the variation of serum 25(OH)D concentrations in a healthy
population. Notably, genetic risk score analysis revealed that non-
carriers of risk alleles of CYP2R1 rs10741657 and rs10766197,
and/or GC rs4588 and rs842999 had statistically significantly
higher serum 25(OH)D concentrations compared to carriers of all
risk alleles.
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